Skip to content
Home/Companies/Biotech/Ultragenyx

Ultragenyx

Biotech·United States·Exited 2014·Held 3yr
Entry
2011
Hold
3yr
Exit
2014

Who owns Ultragenyx?

Ultragenyx is an American Biotech company, formerly owned by HealthCap, exited in 2014 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap VI · 2008 · VC

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Exit Type
IPO
Exit Year
2014

More from HealthCap VI

Other portfolio companies in the same fund.

GenSight Biologics S.A.
Exited 2016
BiotechFrance· 2015
Glionova AB
Active
BiotechSweden· 2014
Xeris Biopharma Holdings, Inc (Strongbridge)
Exited 2021
PharmaUS· 2014
to Xeris Pharmaceuticals
Nordic Nanovector AS
Exited 2015
BiotechNO· 2013
Oncopeptides AB
Exited 2017
BiotechSE· 2013
Wilson Therapeutics AB
Exited 2018
PharmaSweden· 2012
to Alexion Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Ultragenyx?

Ultragenyx was formerly owned by HealthCap, exited in 2014. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue